聚四氟乙烯双瓣叶肺动脉瓣置换术的远期结局
该回顾性研究分析了119例接受0.1毫米聚四氟乙烯(PTFE)双瓣叶肺动脉瓣置换术患者的远期结局,中位随访9.5年。5年和10年生存率均为96.5%,免于再干预率分别为90.0%和63.3%,免于结构性瓣膜 deterioration(SVD)率分别为92.8%和51.1%。较小瓣膜直径和出院时超过轻度的肺动脉瓣反流是再干预或SVD的危险因素。
要点
- PTFE双瓣叶肺动脉瓣置换术远期结果可接受,但耐久性有待提高。
- 10年免于再干预率63.3%,免于SVD率51.1%,反流为主要SVD模式。
- 较小瓣膜直径和出院时超过轻度肺动脉瓣反流是再干预或SVD的危险因素。
核心结论
- PTFE双瓣叶肺动脉瓣置换术的远期结果可接受,但可能需要改进以减少技术误差并提高耐久性。
- 较小瓣膜直径和出院时超过轻度的肺动脉瓣反流是再干预或SVD的危险因素,需要仔细随访以及时再干预。
研究设计与样本
- 回顾性 review of 原始119例接受PTFE双瓣叶肺动脉瓣置换术的患者,中位年龄16.9岁(范围0.4-57.1)。
- 再干预定义为对PTFE瓣膜的任何外科或经皮导管操作;SVD定义为随访超声心动图出现峰值压力阶差≥50 mm Hg或至少中度肺动脉瓣反流。
主要发现
- 中位随访9.5年,5年和10年生存率均为96.5%,早期死亡2例,晚期死亡2例。
- 5年免于再干预率90.0%,10年63.3%;5年免于SVD率92.8%,10年51.1%,反流为主要模式(64.6%)。
- 5年和10年免于再干预和SVD率分别为89.1%和49.5%。
- 多变量分析显示较小瓣膜直径(风险比0.82;P < .001)和出院时超过轻度的肺动脉瓣反流(风险比5.81;P < .001)是再干预或SVD的危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2016 we reported promising midterm outcomes of bicuspid pulmonary valve replacement using 0.1-mm polytetrafluoroethylene (PTFE) membrane. This follow-up study analyzes long-term outcomes and risk factors for reintervention and structural valve deterioration (SVD). METHODS: We performed a retrospective review of the original 119 patients who underwent PTFE bicuspid pulmonary valve replacement. Median patient age was 16.9 years (range, 0.4-57.1). Reintervention was defined as any surgical or percutaneous catheter procedure on the PTFE valve. SVD was defined as development of a peak pressure gradient ≥ 50 mm Hg or at least a moderate amount of pulmonary regurgitation on follow-up echocardiography. RESULTS: The median follow-up duration was 9.5 years. The survival rate was 96.5% at 5 and 10 years, with 2 early and 2 late mortalities. Freedom from reintervention was 90.0% at 5 years and 63.3% at 10 years. Freedom from SVD was 92.8% at 5 years and 51.1% at 10 years, with regurgitation the predominant mode (64.6%). Freedom from both reintervention and SVD at 5 and 10 years were 89.1% and 49.5%, respectively. Multivariable analysis identified smaller valve diameter (hazard ratio, 0.82; P < .001) and more than trivial pulmonary regurgitation at discharge (hazard ratio, 5.81; P < .001) as risk factors for reintervention or SVD. CONCLUSIONS: Long-term results of the PTFE bicuspid pulmonary valve replacement were acceptable. However, improvements may be needed to reduce technical error and improve durability. Smaller valve diameter and more than trivial pulmonary regurgitation at discharge were risk factors for reintervention or SVD, warranting careful follow-up for timely reintervention.
引用
- Kim ER, Lee C, Lee CH, et al. Long-term Outcomes of Polytetrafluoroethylene Bicuspid Pulmonary Valve Replacement. Ann Thorac Surg. 2023. PMID: 37666352. doi:10.1016/j.athoracsur.2023.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。